Three-Month Outcome of Ziv-Aflibercept for Diabetic Macular Edema
Author:
Publisher
MedCrave Group, LLC
Reference6 articles.
1. Vision-related quality of life in patients with diabetic macular oedema;Hariprasad;Br J Ophthalmol 92(1),2008
2. Vascular Endothelial Growth Factor (VEGF)-Induced Retinal Vascular Permeability Is Mediated by Intercellular Adhesion Molecule-1 (ICAM-1);Miyamoto;Am J Pathol 156(5),2000
3. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial;Wells;Ophthalmology 123(6),2016
4. Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture;Malik;Br J Ophthalmol 98 Suppl 1,2014
5. Ziv-aflibercept in macular disease;Mansour;Br J Ophthalmol 99(8),2015
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A combination of suprachoroidal injection of triamcinolone using a custom-made needle and intravitreal Ziv-aflibercept every eight weeks to manage naïve/denovo central DME: a single-center retrospective case series;International Journal of Retina and Vitreous;2024-04-02
2. Safety of intravitreal ziv-aflibercept in choroido-retinal vascular diseases: A randomised double-blind intervention study;PLOS ONE;2019-10-24
3. Intravitreal Ziv-Aflibercept: A Comprehensive Review;Seminars in Ophthalmology;2019-07-17
4. Using Anti-VEGF in Diabetic Retinopathy;Advances in Ophthalmology & Visual System;2016-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3